We have developed our original tissue engineering technology “cell sheet engineering”
utilizing temperature-responsive culture dishes. The cells are confluently grown on a …

We propose a method for the production of a fiber-shaped three-dimensional (3D) cellular
construct of human induced pluripotent stem cell-derived cardiomyocytes (hiPS-CMs) for the …

Fabrication of cardiac tissue from human induced pluripotent stem cell‐derived
cardiomyocytes (hiPS‐CMs) has received great interest, but a major challenge facing …

Human induced pluripotent stem (iPS) cell-derived cardiomyocytes are used for in vitro
pharmacological and pathological studies worldwide. In particular, the functional …

Analyzing contractile force, the most important and best understood function of
cardiomyocytes in vivo is not established in human induced pluripotent stem cell-derived …

Cardiomyocytes derived from human pluripotent stem cells (hPSC-CMs) hold a great
potential as human in vitro models for studying heart disease and for drug safety screening …

Human induced pluripotent stem cell–derived cardiomyocytes (iPSC-CMs) are regarded as
a promising cell source for establishing in-vitro personalized cardiac tissue models and …

To accelerate the cardiac drug discovery pipeline, we set out to develop a platform that
would be capable of quantifying tissue-level functions such as contractile force and be …

Background: Tissue engineering enables the generation of functional human cardiac tissue
with cells derived in vitro in combination with biocompatible materials. Human-induced …

Since the advent of the generation of human induced pluripotent stem cells (hiPSCs),
numerous protocols have been developed to differentiate hiPSCs into cardiomyocytes and …